Positive Airway Pressure Devices Market Size, Share & Trends Analysis Report By Product (CPAP, APAP, BiPAP), By Application (Obstructive Sleep Apnea, Respiratory Failure), By End-use (Home & Care Settings, Hospitals & Clinics), By Region, And Segment Fore

Positive Airway Pressure Devices Growth & Trends

The global positive airway pressure devices market size is estimated to reach USD 3.63 billion by 2030, registering a CAGR of 5.59% from 2025 to 2030, according to a new report by Grand View Research, Inc. The healthcare industry is facing challenges owing to the rapidly growing prevalence of obstructive sleep apnea and sleep apnea-associated chronic comorbidities. Obstructive sleep apnea is a sleeping disorder, characterized by irregular breathing, thus providing insufficient oxygen to the brain. As per the global prevalence of obstructive sleep apnea estimates published in June 2022 by UpToDate, over 936 million individuals across the globe suffer from mild to severe sleep apnea.

Changing lifestyles owing to globalization and the adoption of unhealthy dietary habits are making individuals prone to obesity, Cardiovascular Diseases (CVDs), diabetes, and hypertension, which are forerunners of obstructive sleep apnea. As per the estimates published by the World Population Review, 36.2% of the U.S. population is diagnosed as obese. In addition, the rapidly increasing geriatric population coupled with increasing life expectancy is anticipated to contribute to the incidence rate of obstructive sleep apnea and directly drive the demand for positive airway pressure devices (PAP) devices. The COVID-19 pandemic restrained the growth of the market owing to multiple lockdowns and travel restrictions imposed by governments across the globe to curb the transmission rate.

In addition, the postponement of elective procedures and infrastructural changes in healthcare facilities to accommodate COVID-19 care facilities negatively impacted the procedural volume, which hindered market growth. Healthcare facilities and sleep centers recorded a declining trend in diagnostic and therapeutic procedural volume, restricting the growth of PAP devices. The American Academy of Sleep Medicine (AASM) introduced protocols to adopt virtual consultations to address the declining sleep studies volume. However, during the initial months of the pandemic, PAP machines were being used as the first line of treatment and as an alternative to ventilators in mechanical ventilation. Global government bodies are devising strategies to promote awareness levels among the population and promote the adoption of PAP machines. The availability of favorable reimbursement policies is further boosting product adoption.

Positive Airway Pressure Devices Market Report Highlights

  • The CPAP devices segment dominated the market in 2024, owing to the growing incidence of obstructive sleep apnea and CPAP is the first line of treatment as it is more economical than other PAP devices
  • North America dominated the market in 2024, owing to the large patient pool, increasing disposable income levels, and presence of favorable insurance coverages
  • The prevalence of obstructive sleep apnea in the male population of North America is recorded to be 15-30% and in females, it is 10-15%
  • Key participants in the market are focusing on innovative product development strategies to expand their product portfolio and address the growing demand
  • Some of the latest features being incorporated in PAP machines are noise reduction and softer material to enhance patient comfort and compliance.
Please note The report will be delivered in 2-3 business days upon order notification.


Chapter 1. Methodology and Scope
1.1. Market Segmentation and Scope
1.2. Market Definitions
1.3. Research Methodology
1.4. Information Procurement
1.4.1. Purchased Database
1.4.2. GVR’s Internal Database
1.5. Details of primary research
1.6. Market Formulation & Validation
1.7. Model Details
1.7.1. Commodity flow analysis (Model 1)
1.7.1.1. Approach 1: Commodity flow approach
1.7.2. Volume price analysis (Model 2)
1.7.2.1. Approach 2: Volume price analysis
1.8. Research Scope and Assumptions
1.8.1. List of Secondary Sources
1.8.2. List of Primary Sources
1.8.3. Objectives
Chapter 2. Executive Summary
2.1. Market Outlook
2.2. Segment Outlook
2.2.1. Product Outlook
2.2.2. Application Outlook
2.2.3. End Use Outlook
2.2.4. Regional Outlook
2.3. Competitive Insights
Chapter 3. Positive Airway Pressure Devices Market Variables, Trends, & Scope
3.1. Market Lineage Outlook
3.1.1. Parent Market Outlook
3.1.2. Related/Ancillary Market Outlook
3.2. Industry Analysis
3.2.1. User Perspective Analysis
3.2.2. Key End Users
3.3. Technology Outlook
3.4. Regulatory Framework
3.5. Market Dynamics
3.5.1. Market Drivers Analysis
3.5.1.1. Rising prevalence of sleep apnea
. Technological advancements
3.5.2. Market Restraints Analysis
3.5.2.1. High cost of devices
3.5.2.2. Patient discomfort and compliance issues
3.5.3. Industry Challenges and Opportunity Analysis
3.6. Positive Airway Pressure Devices Market Analysis Tools
3.6.1. Porter’s Analysis
3.6.1.1. Bargaining power of the suppliers
3.6.1.2. Bargaining power of the buyers
3.6.1.3. Threats of substitution
3.6.1.4. Threats from new entrants
3.6.1.5. Competitive rivalry
3.6.2. PESTEL Analysis
3.6.2.1. Political landscape
3.6.2.2. Economic and Social landscape
3.6.2.3. Technological landscape
3.6.2.4. Environmental landscape
3.6.2.5. Legal landscape
3.7. Major Deals & Strategic Alliances Analysis in the Positive Airway Pressure Devices
3.8. Impact of COVID-19
Chapter 4. Positive Airway Pressure Devices Market: Product Estimates & Trend Analysis
4.1. Definition and Scope
4.2. Product Market Share Analysis, 2024 & 2030
4.3. Segment Dashboard
4.4. Positive Airway Pressure Devices Market: By Product, 2018 to 2030
4.4.1. CPAP
4.4.1.1. CPAP Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
4.4.2. APAP
4.4.2.1. APAP Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
4.4.3. BiPAP
4.4.3.1. BiPAP Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
Chapter 5. Positive Airway Pressure Devices Market: Application Estimates & Trend Analysis
5.1. Definition and Scope
5.2. Application Market Share Analysis, 2024 & 2030
5.3. Segment Dashboard
5.4. Positive Airway Pressure Devices Market: By Application, 2018 to 2030
5.4.1. Obstructive Sleep Apnea
5.4.1.1. Obstructive Sleep Apnea Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
5.4.2. Respiratory Failures
5.4.2.1. Respiratory Failures Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
5.4.3. COPD
5.4.3.1. COPD Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
Chapter 6. Positive Airway Pressure Devices Market: End Use Estimates & Trend Analysis
6.1. Definition and Scope
6.2. End Use Market Share Analysis, 2024 & 2030
6.3. Segment Dashboard
6.4. Positive Airway Pressure Devices Market: By End Use, 2018 to 2030
6.4.1. Hospitals and Clinics
6.4.1.1. Hospitals and Clinics Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
6.4.2. Home Care Settings
6.4.2.1. Home Care Settings Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
6.4.3. Others (Long-Term Care Facilities, etc.)
6.4.3.1. Others (Long-Term Care Facilities, etc.) Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
Chapter 7. Positive Airway Pressure Devices Market: Regional Estimates & Trend Analysis by Region, Product, Application, End Use
7.1. Definition and Scope
7.2. Regional Market Share Analysis, 2024 & 2030
7.3. Regional Market Dashboard
7.4. Regional Market Snapshot
7.5. SWOT Analysis
7.5.1. North America
7.5.2. Europe
7.5.3. Asia Pacific
7.5.4. Latin America
7.5.5. Middle East & Africa
7.6. Positive Airway Pressure Devices Market Share, By Region, 2024 & 2030 (USD Million)
7.7. North America
7.7.1. North America Positive Airway Pressure Devices Market Estimates and Forecasts, 2018 - 2030 (USD Million)
7.7.2. U.S.
7.7.2.1. Key Country Dynamics
7.7.2.2. Regulatory Landscape/Reimbursement Scenario
7.7.2.3. Competitive Insights
7.7.2.4. U.S. Positive Airway Pressure Devices Market Estimates and Forecasts, 2018 - 2030 (USD Million)
7.7.3. Canada
7.7.3.1. Key Country Dynamics
7.7.3.2. Regulatory Landscape/Reimbursement Scenario
7.7.3.3. Competitive Insights
7.7.3.4. Canada Positive Airway Pressure Devices Market Estimates and Forecasts, 2018 - 2030 (USD Million)
7.7.4. Mexico
7.7.4.1. Key Country Dynamics
7.7.4.2. Regulatory Landscape/Reimbursement Scenario
7.7.4.3. Competitive Insights
7.7.4.4. Canada Positive Airway Pressure Devices Market Estimates and Forecasts, 2018 - 2030 (USD Million)
7.8. Europe
7.8.1. Europe Positive Airway Pressure Devices Market Estimates and Forecasts, 2018 - 2030 (USD Million)
7.8.2. UK
7.8.2.1. Key Country Dynamics
7.8.2.2. Regulatory Landscape/Reimbursement Scenario
7.8.2.3. Competitive Insights
7.8.2.4. U.K. Positive Airway Pressure Devices Market Estimates and Forecasts, 2018 - 2030 (USD Million)
7.8.3. Germany
7.8.3.1. Key Country Dynamics
7.8.3.2. Regulatory Landscape/Reimbursement Scenario
7.8.3.3. Competitive Insights
7.8.3.4. Germany Positive Airway Pressure Devices Market Estimates and Forecasts, 2018 - 2030 (USD Million)
7.8.4. France
7.8.4.1. Key Country Dynamics
7.8.4.2. Regulatory Landscape/Reimbursement Scenario
7.8.4.3. Competitive Insights
7.8.4.4. France Positive Airway Pressure Devices Market Estimates and Forecasts, 2018 - 2030 (USD Million)
7.8.5. Italy
7.8.5.1. Key Country Dynamics
7.8.5.2. Regulatory Landscape/Reimbursement Scenario
7.8.5.3. Competitive Insights
7.8.5.4. Italy Positive Airway Pressure Devices Market Estimates and Forecasts, 2018 - 2030 (USD Million)
7.8.6. Spain
7.8.6.1. Key Country Dynamics
7.8.6.2. Regulatory Landscape/Reimbursement Scenario
7.8.6.3. Competitive Insights
7.8.6.4. Spain Positive Airway Pressure Devices Market Estimates and Forecasts, 2018 - 2030 (USD Million)
7.8.7. Sweden
7.8.7.1. Key Country Dynamics
7.8.7.2. Regulatory Landscape/Reimbursement Scenario
7.8.7.3. Competitive Insights
7.8.7.4. Sweden Positive Airway Pressure Devices Market Estimates and Forecasts, 2018 - 2030 (USD Million)
7.8.8. Denmark
7.8.8.1. Key Country Dynamics
7.8.8.2. Regulatory Landscape/Reimbursement Scenario
7.8.8.3. Competitive Insights
7.8.8.4. Sweden Positive Airway Pressure Devices Market Estimates and Forecasts, 2018 - 2030 (USD Million)
7.8.9. Norway
7.8.9.1. Key Country Dynamics
7.8.9.2. Regulatory Landscape/Reimbursement Scenario
7.8.9.3. Competitive Insights
7.8.9.4. Sweden Positive Airway Pressure Devices Market Estimates and Forecasts, 2018 - 2030 (USD Million)
7.9. Asia Pacific
7.9.1. Asia Pacific Positive Airway Pressure Devices Market Estimates and Forecasts, 2018 - 2030 (USD Million)
7.9.2. China
7.9.2.1. Key Country Dynamics
7.9.2.2. Regulatory Landscape/Reimbursement Scenario
7.9.2.3. Competitive Insights
7.9.2.4. China Positive Airway Pressure Devices Market Estimates and Forecasts, 2018 - 2030 (USD Million)
7.9.3. Japan
7.9.3.1. Key Country Dynamics
7.9.3.2. Regulatory Landscape/Reimbursement Scenario
7.9.3.3. Competitive Insights
7.9.3.4. Japan Positive Airway Pressure Devices Market Estimates and Forecasts, 2018 - 2030 (USD Million)
7.9.4. India
7.9.4.1. Key Country Dynamics
7.9.4.2. Regulatory Landscape/Reimbursement Scenario
7.9.4.3. Competitive Insights
7.9.4.4. India Positive Airway Pressure Devices Market Estimates and Forecasts, 2018 - 2030 (USD Million)
7.9.5. South Korea
7.9.5.1. Key Country Dynamics
7.9.5.2. Regulatory Landscape/Reimbursement Scenario
7.9.5.3. Competitive Insights
7.9.5.4. South Korea Positive Airway Pressure Devices Market Estimates and Forecasts, 2018 - 2030 (USD Million)
7.9.6. Australia
7.9.6.1. Key Country Dynamics
7.9.6.2. Regulatory Landscape/Reimbursement Scenario
7.9.6.3. Competitive Insights
7.9.6.4. Australia Positive Airway Pressure Devices Market Estimates and Forecasts, 2018 - 2030 (USD Million)
7.9.7. Thailand
7.9.7.1. Key Country Dynamics
7.9.7.2. Regulatory Landscape/Reimbursement Scenario
7.9.7.3. Competitive Insights
7.9.7.4. Thailand Positive Airway Pressure Devices Market Estimates and Forecasts, 2018 - 2030 (USD Million)
7.10. Latin America
7.10.1. Latin America Positive Airway Pressure Devices Market Estimates and Forecasts, 2018 - 2030 (USD Million)
7.10.2. Brazil
7.10.2.1. Key Country Dynamics
7.10.2.2. Regulatory Landscape/Reimbursement Scenario
7.10.2.3. Competitive Insights
7.10.2.4. Brazil Positive Airway Pressure Devices Market Estimates and Forecasts, 2018 - 2030 (USD Million)
7.10.3. Argentina
7.10.3.1. Key Country Dynamics
7.10.3.2. Regulatory Landscape/Reimbursement Scenario
7.10.3.3. Competitive Insights
7.10.3.4. Argentina Positive Airway Pressure Devices Market Estimates and Forecasts, 2018 - 2030 (USD Million)
7.11. Middle East and Africa
7.11.1. Middle East and Africa Positive Airway Pressure Devices Market Estimates and Forecasts, 2018 - 2030 (USD Million)
7.11.2. South Africa
7.11.2.1. Key Country Dynamics
7.11.2.2. Regulatory Landscape/Reimbursement Scenario
7.11.2.3. Competitive Insights
7.11.2.4. South Africa Positive Airway Pressure Devices Market Estimates and Forecasts, 2018 - 2030 (USD Million)
7.11.3. Saudi Arabia
7.11.3.1. Key Country Dynamics
7.11.3.2. Regulatory Landscape/Reimbursement Scenario
7.11.3.3. Competitive Insights
7.11.3.4. Saudi Arabia Positive Airway Pressure Devices Market Estimates and Forecasts, 2018 - 2030 (USD Million)
7.11.4. UAE
7.11.4.1. Key Country Dynamics
7.11.4.2. Regulatory Landscape/Reimbursement Scenario
7.11.4.3. Competitive Insights
7.11.4.4. UAE Positive Airway Pressure Devices Market Estimates and Forecasts, 2018 - 2030 (USD Million)
7.11.5. Kuwait
7.11.5.1. Key Country Dynamics
7.11.5.2. Regulatory Landscape/Reimbursement Scenario
7.11.5.3. Competitive Insights
7.11.5.4. UAE Positive Airway Pressure Devices Market Estimates and Forecasts, 2018 - 2030 (USD Million)
Chapter 8. Competitive Landscape
8.1. Recent Developments & Impact Analysis by Key Market Participants
8.2. Company Categorization
8.3. Company Market Share Analysis
8.4. Company Heat Map Analysis
8.5. Company Profiles
8.5.1. Koninklijke Philips N.V.
8.5.1.1. Participant’s Overview
8.5.1.2. Financial Performance
8.5.1.3. Product Benchmarking
8.5.1.4. Strategy Mapping
8.5.2. Fisher & Paykel Healthcare Limited
8.5.2.1. Participant’s Overview
8.5.2.2. Financial Performance
8.5.2.3. Product Benchmarking
8.5.2.4. Strategy Mapping
8.5.3. Curative, Inc.
8.5.3.1. Participant’s Overview
8.5.3.2. Financial Performance
8.5.3.3. Product Benchmarking
8.5.3.4. Strategy Mapping
8.5.4. ResMed
8.5.4.1. Participant’s Overview
8.5.4.2. Financial Performance
8.5.4.3. Product Benchmarking
8.5.4.4. Strategy Mapping
8.5.5. Drive DeVilbiss Healthcare
8.5.5.1. Participant’s Overview
8.5.5.2. Financial Performance
8.5.5.3. Product Benchmarking
8.5.5.4. Strategy Mapping
8.5.6. Medtronic
8.5.6.1. Participant’s Overview
8.5.6.2. Financial Performance
8.5.6.3. Product Benchmarking
8.5.6.4. Strategy Mapping
8.5.7. Servona GmbH
8.5.7.1. Participant’s Overview
8.5.7.2. Financial Performance
8.5.7.3. Product Benchmarking
8.5.7.4. Strategy Mapping
8.5.8. Armstrong Medical Inc.
8.5.8.1. Participant’s Overview
8.5.8.2. Financial Performance
8.5.8.3. Product Benchmarking
8.5.8.4. Strategy Mapping
8.5.9. Medical Depot Inc.
8.5.9.1. Participant’s Overview
8.5.9.2. Financial Performance
8.5.9.3. Product Benchmarking
8.5.9.4. Strategy Mapping
8.5.10. Smiths Group plc
8.5.10.1. Participant’s Overview
8.5.10.2. Financial Performance
8.5.10.3. Product Benchmarking
8.5.10.4. Strategy Mapping
8.5.11. Löwenstein Medical UK Ltd.
8.5.11.1. Participant’s Overview
8.5.11.2. Financial Performance
8.5.11.3. Product Benchmarking
8.5.11.4. Strategy Mapping

Download our eBook: How to Succeed Using Market Research

Learn how to effectively navigate the market research process to help guide your organization on the journey to success.

Download eBook
Cookie Settings